Ventavia Research Group, LLC — Fort Worth, Texas

Ventavia Research Group, LLC is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Ventavia Research Group, LLC has participated in 18 clinical trials.

Therapeutic areas: Respiratory Syncytial Viruses, Respiratory Tract Diseases, Meningococcal Vaccine.

Sponsors: Janssen Vaccines & Prevention B.V., Pfizer, H. Lundbeck A/S.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ventavia Research Group, LLC?

Ventavia Research Group, LLC has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ventavia Research Group, LLC conducted?

Ventavia Research Group, LLC has 18 clinical trials on record. Their work covers Respiratory Syncytial Viruses, Respiratory Tract Diseases, Meningococcal Vaccine.

Is Ventavia Research Group, LLC accredited by Crixeo Health?

Yes — Ventavia Research Group, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Ventavia Research Group, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.